Drug intelligence / Profile preview

AccuHist DM

Development stage
Unknown
Lead developer
Atley Pharmaceuticals
Modality
Small Molecules
Administration
Oral
01

Overview

AccuHist DM is a multi-ingredient over-the-counter (OTC) combination medication used for the symptomatic relief of the common cold, influenza, allergies, and other respiratory conditions such as sinusitis and bronchitis. It contains four active small molecule components: brompheniramine maleate (an antihistamine), dextromethorphan hydrobromide (a cough suppressant), pseudoephedrine hydrochloride (a nasal decongestant), and guaifenesin (an expectorant). Brompheniramine acts as a competitive H1 receptor antagonist to alleviate allergic symptoms like sneezing and runny nose. Dextromethorphan acts centrally on the cough center in the medulla to elevate the cough threshold. Pseudoephedrine is a sympathomimetic amine that stimulates alpha-adrenergic receptors in the nasal mucosa to produce vasoconstriction and reduce swelling. Guaifenesin increases the volume and reduces the viscosity of respiratory tract secretions, facilitating their removal. The product is primarily formulated for pediatric use as oral drops or syrup.

Brand names
AccuHist DM
02

Targets

SIGMAR1 (Sigma non-opioid intracellular receptor 1)SERT (Sodium-dependent serotonin transporter)ADRB1 (β1)ADRA1 (Alpha-1 adrenergic receptor family)NMDAR (Glutamate receptor ionotropic, NMDA)HRH1 (Histamine H1 Receptor)mAChR (Muscarinic acetylcholine receptors)

Beyond the preview

Go deeper on AccuHist DM.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on AccuHist DM.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call